v3.25.4
Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 5 Months Ended 9 Months Ended
Aug. 07, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2025
Mar. 31, 2025
Subsidiary, Sale of Stock [Line Items]            
Cash   $ 281,173     $ 281,173 $ 64,357
Cash equivalents   0     0 $ 0
Federal depository insurance corporation   250,000     250,000  
Offering costs   4,459,070     4,459,070  
Underwriting fees         3,898,500  
Legal and other expenses         560,570  
Ordinary shares are subject to forfeiture   378,000     378,000  
Over-allotment option to purchase $ 1,080,000          
Allocation of income (loss)   521,600 $ (3,840) $ (15,929) 415,822  
Denominator:            
Unrecognized tax benefits   0     0  
Accrued for interest and penalties   0     0  
Redeemable Shares [Member]            
Subsidiary, Sale of Stock [Line Items]            
Allocation of income (loss)   $ 378,625 $ 246,506  
Denominator:            
Basic and diluted weighted average shares outstanding [1]   8,280,000 4,395,927  
Basic and diluted net income (loss) per ordinary share   $ 0.05 $ 0.06  
Non Redeemable Shares [Member]            
Subsidiary, Sale of Stock [Line Items]            
Allocation of income (loss)   $ 142,975 $ (3,840) $ (15,929) $ 169,316  
Denominator:            
Basic and diluted weighted average shares outstanding [1]   3,126,650 2,898,000 2,898,000 3,019,392  
Basic and diluted net income (loss) per ordinary share   $ 0.05 $ (0.00) $ (0.01) $ 0.06  
IPO [Member]            
Subsidiary, Sale of Stock [Line Items]            
Underwriting fees         $ 3,898,500  
Sale of stock, shares 8,280,000          
[1] Ordinary shares have been retroactively restated to reflect the first amendment to the Subscription Agreement, which allowed the Sponsor to increase the purchase of ordinary shares from 2,415,000 to 2,898,000 shares for $25,000, including an aggregate of up to 378,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5 ).